M-CSF
CSF1proteinM-CSF (CSF1) is a macrophage growth factor that recruits and activates monocytes, amplifying plaque inflammation in Type 1 MI and post-MI complications.
Pathway placement
Cascade stepPlaque inflammation
Confidencehigh
RationaleMacrophage colony-stimulating factor driving monocyte recruitment and plaque inflammation.
Druggability
DruggableYes
Known drugs / candidates2
Small-molecule tractableNo
Antibody tractableYes
EnsemblENSG00000184371
Type I vs Type II discrimination
ScoresLow-confidence (proxy)
R — rupture / Type-I45
C — confounder / Type-II78
A — assay feasibility72
E — evidence strength29
T1DI (composite)7
Specificity differential (R−C)-32.6
Confounder panel (Type-II drivers)
No confounder evidence retrieved.
Tier: light (literature co-occurrence proxy — lower confidence). See the discrimination table for all markers.
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)
Literature evidence(3)
- Inflammatory biomarkers and risk of cardiovascular events in patients undergoing coronary angiography.American heart journal · 2022 · PMID 35753356 · doi
- Exploring the "gene-protein-metabolite" network of coronary heart disease with phlegm and blood stasis syndrome by integrated multi-omics strategy.Frontiers in pharmacology · 2022 · PMID 36523490 · doi
- Antiinflammatory effects of aspirin in ACS: relevant to its cardiocoronary actions?Thrombosis and haemostasis · 2015 · PMID 26085050 · doi